Ariad Pharma (ARIA ) Posts Q3 Loss of 32c/Share

Ariad Pharma (NASDAQ: ARIA ) reported Q3 EPS of ($0.32), $0.05 worse than the analyst estimate of ($0.27).

For earnings history and earnings-related data on Ariad Pharma (ARIA ) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Calamp Corp. (CAMP) Misses Q2 EPS by 33c
• Calidi Biotherapeutics (CLDI) Reports Q2 Loss of $2.94